메뉴 건너뛰기




Volumn 79, Issue 7, 2007, Pages 911-918

Characteristics of lamivudine-resistant Hepatitis B Virus (HBV) strains with and without breakthrough hepatitis in patients with chronic hepatitis B evaluated by serial HBV full-genome sequences

Author keywords

Breakthrough hepatitis; Chronic hepatitis B; Hepatitis B virus; Lamivudine resistance

Indexed keywords

DNA POLYMERASE; LAMIVUDINE; VIRUS DNA;

EID: 34249887139     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20915     Document Type: Article
Times cited : (5)

References (27)
  • 1
    • 0037235229 scopus 로고    scopus 로고
    • Long-term prognosis by lamivudine monotherapy for severe acute exacerbation in chronic hepatitis B infection: Emergence of YMDD motif mutant and risk of breakthrough hepatitis - an open-cohort study
    • Akuta N, Tsubota A, Suzuki F, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kumada H. 2003. Long-term prognosis by lamivudine monotherapy for severe acute exacerbation in chronic hepatitis B infection: Emergence of YMDD motif mutant and risk of breakthrough hepatitis - an open-cohort study. J Hepatol 38:91-97.
    • (2003) J Hepatol , vol.38 , pp. 91-97
    • Akuta, N.1    Tsubota, A.2    Suzuki, F.3    Suzuki, Y.4    Hosaka, T.5    Someya, T.6    Kobayashi, M.7    Saitoh, S.8    Arase, Y.9    Ikeda, K.10    Kumada, H.11
  • 2
    • 0031780935 scopus 로고    scopus 로고
    • Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group
    • Allen MI, Deslauriers M, Andrews CW, Tippies GA, Walters KA, Tyrrell DL, Brown N, Condreay LD. 1998. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology 27:1670-1677.
    • (1998) Hepatology , vol.27 , pp. 1670-1677
    • Allen, M.I.1    Deslauriers, M.2    Andrews, C.W.3    Tippies, G.A.4    Walters, K.A.5    Tyrrell, D.L.6    Brown, N.7    Condreay, L.D.8
  • 4
    • 0037230411 scopus 로고    scopus 로고
    • Complete genome sequence of hepatitis B virus (HBV) from a patient with fulminant hepatitis without precore and core promoter mutations: Comparison with HBV from a patient with acute hepatitis infected from the same infectious source
    • Chen Y, Michitaka K, Matsubara H, Yamamoto K, Horiike N, Onji M. 2003. Complete genome sequence of hepatitis B virus (HBV) from a patient with fulminant hepatitis without precore and core promoter mutations: Comparison with HBV from a patient with acute hepatitis infected from the same infectious source. J Hepatol 38:84-90.
    • (2003) J Hepatol , vol.38 , pp. 84-90
    • Chen, Y.1    Michitaka, K.2    Matsubara, H.3    Yamamoto, K.4    Horiike, N.5    Onji, M.6
  • 5
    • 0028916425 scopus 로고
    • Hepatitis B virus immunopathogenesis
    • Chisari FV. 1995. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13:29-60.
    • (1995) Annu Rev Immunol , vol.13 , pp. 29-60
    • Chisari, F.V.1
  • 8
    • 0036590392 scopus 로고    scopus 로고
    • Activation and maturation of antigen-presenting dendritic cells during vaccine therapy in patients with chronic hepatitis due to hepatitis B virus
    • Horiike N, Akbar SMF, Ninomiya T, Abe M, Michitaka K, Onji M. 2002. Activation and maturation of antigen-presenting dendritic cells during vaccine therapy in patients with chronic hepatitis due to hepatitis B virus. Hepatol Res 23:38-47.
    • (2002) Hepatol Res , vol.23 , pp. 38-47
    • Horiike, N.1    Akbar, S.M.F.2    Ninomiya, T.3    Abe, M.4    Michitaka, K.5    Onji, M.6
  • 9
    • 11844306534 scopus 로고    scopus 로고
    • In vivo immunization by vaccine therapy following virus suppression by lamivudine: A novel approach for treating patients with chronic hepatitis B
    • Horiike N, Akbar SMF, Michitaka K, Joukou K, Yamamoto K, Kojima N, Hiasa Y, Abe M, Onji M. 2005. In vivo immunization by vaccine therapy following virus suppression by lamivudine: A novel approach for treating patients with chronic hepatitis B. J Clin Virol 32:156-161.
    • (2005) J Clin Virol , vol.32 , pp. 156-161
    • Horiike, N.1    Akbar, S.M.F.2    Michitaka, K.3    Joukou, K.4    Yamamoto, K.5    Kojima, N.6    Hiasa, Y.7    Abe, M.8    Onji, M.9
  • 10
    • 0036461318 scopus 로고    scopus 로고
    • Immunology of hepatitis B infection
    • Jung M-C, Pape GR. 2002. Immunology of hepatitis B infection. Lancet Infect Dis 2:43-50.
    • (2002) Lancet Infect Dis , vol.2 , pp. 43-50
    • Jung, M.-C.1    Pape, G.R.2
  • 11
    • 0346786525 scopus 로고    scopus 로고
    • Continued lamivudine therapy in patients with chronic hepatitis B
    • Kumada H. 2003. Continued lamivudine therapy in patients with chronic hepatitis B. Intervirology 46:377-387.
    • (2003) Intervirology , vol.46 , pp. 377-387
    • Kumada, H.1
  • 14
    • 0032783679 scopus 로고    scopus 로고
    • Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy
    • Liaw YF, Chien RN, Yeh CT, Tsai SL, Chu CM. 1999. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy. Hepatology 30:567-572.
    • (1999) Hepatology , vol.30 , pp. 567-572
    • Liaw, Y.F.1    Chien, R.N.2    Yeh, C.T.3    Tsai, S.L.4    Chu, C.M.5
  • 15
    • 10844242136 scopus 로고    scopus 로고
    • High frequency of functional anti-YMDD and mutant cytotoxic T lymphocytes after in vitro expansion correlates with successful response to lamivudine therapy for chronic hepatitis B
    • Lin CL, Tsal SL, Lee TH, Chien RN, Liao SK, Liaw YF. 2005. High frequency of functional anti-YMDD and mutant cytotoxic T lymphocytes after in vitro expansion correlates with successful response to lamivudine therapy for chronic hepatitis B. Gut: 54:152-161.
    • (2005) Gut , vol.54 , pp. 152-161
    • Lin, C.L.1    Tsal, S.L.2    Lee, T.H.3    Chien, R.N.4    Liao, S.K.5    Liaw, Y.F.6
  • 16
    • 84984548357 scopus 로고    scopus 로고
    • Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full-length viral sequences
    • Liu CJ, Chen PJ, Lai MY, Kao JH, Chen DS. 2001. Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full-length viral sequences. Hepatology 34:583-589.
    • (2001) Hepatology , vol.34 , pp. 583-589
    • Liu, C.J.1    Chen, P.J.2    Lai, M.Y.3    Kao, J.H.4    Chen, D.S.5
  • 18
    • 0027142488 scopus 로고
    • Long-term follow-up of chronic hepatitis B patients treated with Interferon alpha
    • Lok AS, Chung HT, Liu VW, Ma OC. 1993. Long-term follow-up of chronic hepatitis B patients treated with Interferon alpha. Gastroenterology 105:1833-1835.
    • (1993) Gastroenterology , vol.105 , pp. 1833-1835
    • Lok, A.S.1    Chung, H.T.2    Liu, V.W.3    Ma, O.C.4
  • 19
    • 0000532607 scopus 로고
    • Epidemiology of viral hepatitis
    • Mast EE, Alter MJ. 1993. Epidemiology of viral hepatitis. Sem Virol 4:273-283.
    • (1993) Sem Virol , vol.4 , pp. 273-283
    • Mast, E.E.1    Alter, M.J.2
  • 20
    • 0032880610 scopus 로고    scopus 로고
    • Novel pattern of amino acid mutation in the hepatitis B virus polymerase in association with resistance to lamivudine therapy in Japanese patients with chronic hepatitis B
    • Ogata N, Fujii K, Takigawa S, Nomoto M, Ichida T, Asakura H. 1999. Novel pattern of amino acid mutation in the hepatitis B virus polymerase in association with resistance to lamivudine therapy in Japanese patients with chronic hepatitis B. J Med Virol 59:270-276.
    • (1999) J Med Virol , vol.59 , pp. 270-276
    • Ogata, N.1    Fujii, K.2    Takigawa, S.3    Nomoto, M.4    Ichida, T.5    Asakura, H.6
  • 21
    • 0001852147 scopus 로고    scopus 로고
    • Influence of B domain mutation (L528M) of the hepatitis B virus polymerase on replication ability and resistance to nucleoside analogues
    • Ono-Nita SK, Kato N, Shiratori Y, Yoshida H, Kato J, Goto T. 2000. Influence of B domain mutation (L528M) of the hepatitis B virus polymerase on replication ability and resistance to nucleoside analogues. Hepatology 32:393A.
    • (2000) Hepatology , vol.32
    • Ono-Nita, S.K.1    Kato, N.2    Shiratori, Y.3    Yoshida, H.4    Kato, J.5    Goto, T.6
  • 23
    • 0031033174 scopus 로고    scopus 로고
    • Clinical implications of lamivudine resistance by HBV
    • Schalm SW. 1997. Clinical implications of lamivudine resistance by HBV. Lancet 9044:3-4.
    • (1997) Lancet , vol.9044 , pp. 3-4
    • Schalm, S.W.1
  • 24
    • 3543081472 scopus 로고    scopus 로고
    • Basal core promoter and precore mutations in the Hepatitis B virus genome enhance replication efficacy of lamivudine-resistant mutants
    • Tacke F, Gejrke C, Kuedde T, Heim A, Manns MP, Trautwein C. 2004. Basal core promoter and precore mutations in the Hepatitis B virus genome enhance replication efficacy of lamivudine-resistant mutants. J Virol 78:8524-8535.
    • (2004) J Virol , vol.78 , pp. 8524-8535
    • Tacke, F.1    Gejrke, C.2    Kuedde, T.3    Heim, A.4    Manns, M.P.5    Trautwein, C.6
  • 25
    • 0033000134 scopus 로고    scopus 로고
    • Serological detection of hepatitis B genotype by ELISA with monoclonal antibodies to type specific epitopes in the preS2-region products
    • Usuda S, Okamoto H, Iwanari H, Baba K, Tsuda F, Miyakawa Y, Mayumi M. 1999. Serological detection of hepatitis B genotype by ELISA with monoclonal antibodies to type specific epitopes in the preS2-region products. J Viral Methods 80:97-112.
    • (1999) J Viral Methods , vol.80 , pp. 97-112
    • Usuda, S.1    Okamoto, H.2    Iwanari, H.3    Baba, K.4    Tsuda, F.5    Miyakawa, Y.6    Mayumi, M.7
  • 26
    • 0034802516 scopus 로고    scopus 로고
    • Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy
    • Yuen MF, Sablon E, Hui CK, Yuan HJ, Decraemer H, Lai CL. 2001. Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy. Hepatology 34: 758-791.
    • (2001) Hepatology , vol.34 , pp. 758-791
    • Yuen, M.F.1    Sablon, E.2    Hui, C.K.3    Yuan, H.J.4    Decraemer, H.5    Lai, C.L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.